Phillip Pang, Chief Medical Officer at Vir Biotechnology, Inc. (VIR), sold 5,000 shares at $25.95 ($130K) on 2023-06-07, disclosed to the SEC on 2023-06-08.
Scheduled sale ($130k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| VIR | SELL | 2023-02-28 | $238K | — | Filing → |
| VIR | SELL | 2023-02-24 | $149K | — | Filing → |
| VIR | SELL | 2023-02-21 | $142K | — | Filing → |